| 1 | Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines | 3.3 | 6 | Citations (PDF) |
| 2 | Outreach strategies to promote HIV testing and linkage-to-care focusing on a young sexual and gender-diverse population in Bangkok, Thailand | 2.5 | 4 | Citations (PDF) |
| 3 | Immunogenicity and safety of BNT162b2 vaccination in adolescents with systemic lupus erythematosus | 1.7 | 5 | Citations (PDF) |
| 4 | A pilot program of HIV pre-exposure prophylaxis in Thai youth | 2.5 | 3 | Citations (PDF) |
| 5 | Economic burden of varicella in Bangkok, Thailand: A multicenter medical chart review study | 2.2 | 0 | Citations (PDF) |
| 6 | Lamivudine dosing for preterm infants exposed to HIV: a population pharmacokinetic modelling and simulation study | 3.2 | 1 | Citations (PDF) |
| 7 | Immunogenicity of BNT162b2 as a first booster after a ChAdOx1 primary series in a Thai geriatric population living with frailty | 3.1 | 2 | Citations (PDF) |
| 8 | In‐host modeling of dengue virus and non‐structural protein 1 and the effects of ivermectin in patients with acute dengue fever | 2.8 | 2 | Citations (PDF) |
| 9 | Immunogenicity and safety of tixagevimab-cilgavimab for COVID-19 pre-exposure prophylaxis in immunocompromised 20 to <40 kg children and adolescents: A pilot, prospective, open-labeled study | 3.4 | 0 | Citations (PDF) |
| 10 | Alcohol use, suicidality and virologic non‐suppression among young adults with perinatally acquired HIV in Thailand: a cross‐sectional study | 3.6 | 7 | Citations (PDF) |
| 11 | Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand | 3.1 | 8 | Citations (PDF) |
| 12 | Antimicrobial use for the management of varicella in Thailand: a retrospective observational study | 2.2 | 1 | Citations (PDF) |
| 13 | Immunogenicity and Reactogenicity of Messenger RNA Coronavirus Disease 2019 Vaccine Booster Administered by Intradermal or Intramuscular Route in Thai Older Adults | 4.0 | 7 | Citations (PDF) |
| 14 | Outcomes among Thai children with risk conditions hospitalized for pneumococcal disease (invasive or non-bacteraemic pneumonia): A multi-centre, observational study | 1.6 | 3 | Citations (PDF) |
| 15 | A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women | 3.3 | 12 | Citations (PDF) |
| 16 | Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women | 3.4 | 6 | Citations (PDF) |
| 17 | Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5–11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial | 3.3 | 3 | Citations (PDF) |
| 18 | A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age | 3.3 | 11 | Citations (PDF) |
| 19 | Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution | 3.1 | 5 | Citations (PDF) |
| 20 | Switching efavirenz to rilpivirine in virologically suppressed adolescents with HIV: a multi‐centre 48‐week efficacy and safety study in Thailand | 3.6 | 3 | Citations (PDF) |
| 21 | Polyneuritis Cranialis Associated with BNT162b2 mRNA COVID-19 Vaccine in a Healthy Adolescent | 3.1 | 5 | Citations (PDF) |
| 22 | COVID-19 vaccine boosters in the Asia-Pacific region in the context of Omicron | 3.0 | 10 | Citations (PDF) |
| 23 | Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis | 3.6 | 12 | Citations (PDF) |
| 24 | Comparison of safety and immunogenicity of CoronaVac and ChAdOx1 against the SARS-CoV-2 circulating variants of concern (Alpha, Delta, Beta) in Thai healthcare workers | 1.8 | 33 | Citations (PDF) |
| 25 | Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial | 4.8 | 32 | Citations (PDF) |
| 26 | Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial | 2.9 | 8 | Citations (PDF) |
| 27 | Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults | 3.4 | 27 | Citations (PDF) |
| 28 | Streptococcus pneumoniae Causing Invasive Diseases in Children and Adults in Central Thailand, 2012–2016 | 3.1 | 11 | Citations (PDF) |
| 29 | Early treatment of Favipiravir in COVID-19 patients without pneumonia: a multicentre, open-labelled, randomized control study | 6.4 | 26 | Citations (PDF) |
| 30 | Neonatal Multisystem Inflammatory Syndrome (MIS-N): The First Case Report in ThailandCovid, 2022, 2, 1265-1269 | 1.1 | 5 | Citations (PDF) |
| 31 | Evaluation of the Safety and Immunogenicity of Fractional Intradermal COVID-19 Vaccines as a Booster: A Pilot Study | 3.1 | 11 | Citations (PDF) |
| 32 | The Outcomes of Transition from Pediatrics to Adult Care among Adolescents and Young Adults with HIV at a Tertiary Care Center in Bangkok | 1.7 | 10 | Citations (PDF) |
| 33 | Continuous Prophylactic Antiretrovirals/Antiretroviral Therapy Since Birth Reduces Seeding and Persistence of the Viral Reservoir in Children Vertically Infected With Human Immunodeficiency Virus | 5.6 | 21 | Citations (PDF) |
| 34 | Identification, Management, and Outcomes of Combination Antiretroviral Treatment Failure in Adolescents With Perinatal Human Immunodeficiency Virus Infection in Asia | 5.6 | 5 | Citations (PDF) |
| 35 | Pneumococcal disease in Thailand | 2.3 | 11 | Citations (PDF) |
| 36 | Disclosure of HIV status to sexual partners among perinatally HIV–infected youth in Thailand | 1.3 | 4 | Citations (PDF) |
| 37 | Response of Severe EV71-Infected Patients to Hyperimmune Plasma Treatment: A Pilot Study | 3.1 | 2 | Citations (PDF) |
| 38 | Author response: Within-host evolutionary dynamics of seasonal and pandemic human influenza A viruses in young children 2021, , | | 0 | Citations (PDF) |
| 39 | Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide in adolescents and children with HIV: week 48 results of a single-arm, open-label, multicentre, phase 2/3 trial | 5.7 | 19 | Citations (PDF) |
| 40 | Increased Burden of Concordant and Sequential Anogenital Human Papillomavirus Infections Among Asian Young Adult Women With Perinatally Acquired HIV Compared With HIV-Negative Peers | 1.3 | 2 | Citations (PDF) |
| 41 | Kinetic Changes of Peripheral Blood Monocyte Subsets and Expression of Co-Stimulatory Molecules during Acute Dengue Virus Infection | 3.1 | 3 | Citations (PDF) |
| 42 | Peritransition Outcomes of Southeast Asian Adolescents and Young Adults With HIV Transferring From Pediatric to Adult Care | 1.9 | 9 | Citations (PDF) |
| 43 | Incidence and Persistence of High-risk Anogenital Human Papillomavirus Infection Among Female Youth With and Without Perinatally Acquired Human Immunodefiency Virus Infection: A 3-year Observational Cohort Study | 5.6 | 13 | Citations (PDF) |
| 44 | Immunogenicity and Safety of an MF59-adjuvanted Quadrivalent Seasonal Influenza Vaccine in Young Children at High Risk of Influenza-associated Complications: A Phase III, Randomized, Observer-blind, Multicenter Clinical Trial | 1.3 | 7 | Citations (PDF) |
| 45 | Prevalence of High-risk Nonavalent Vaccine-type Human Papillomavirus Infection Among Unvaccinated, Sexually Active Asian Female Adolescents With and Without Perinatally Acquired HIV Infection | 1.3 | 2 | Citations (PDF) |
| 46 | Time‐varying age‐ and CD4‐stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium | 3.6 | 9 | Citations (PDF) |
| 47 | Use of Animal Models in Studying Roles of Antibodies and Their Secretion Cells in Dengue Vaccine Development | 3.4 | 4 | Citations (PDF) |
| 48 | HIV seronegativity in children, adolescents and young adults living with perinatally acquired HIV: A cross‐sectional study in Thailand | 3.6 | 1 | Citations (PDF) |
| 49 | Predictors of Viremia in Postpartum Women on Antiretroviral Therapy | 1.9 | 8 | Citations (PDF) |
| 50 | Adipocytokine dysregulation, abnormal glucose metabolism, and lipodystrophy in HIV-infected adolescents receiving protease inhibitors | 3.5 | 6 | Citations (PDF) |
| 51 | Incidence, Persistence, and Factors Associated With HPV Infection Among Male Adolescents With and Without Perinatally Acquired HIV Infection | 1.9 | 8 | Citations (PDF) |
| 52 | Use and Outcomes of Antiretroviral Monotherapy and Treatment Interruption in Adolescents With Perinatal HIV Infection in Asia | 1.9 | 0 | Citations (PDF) |
| 53 | Human papillomavirus infection among male adolescents and young adults with perinatally-acquired HIV and without HIV in Thailand | 1.3 | 4 | Citations (PDF) |
| 54 | Clinical features and outcomes of Bacille Calmette-Guérin (BCG)-induced diseases following neonatal BCG Tokyo-172 strain immunization | 3.3 | 2 | Citations (PDF) |
| 55 | Impact of the frequency of plasma viral load monitoring on treatment outcomes among children with perinatally acquired <scp>HIV</scp> | 3.6 | 2 | Citations (PDF) |
| 56 | Burden of varicella in the Asia-Pacific region: a systematic literature review | 4.1 | 32 | Citations (PDF) |
| 57 | Disease- and Treatment-related Morbidity in Adolescents With Perinatal HIV Infection in Asia | 1.3 | 8 | Citations (PDF) |
| 58 | Longitudinal study on enterovirus A71 and coxsackievirus A16 genotype/subgenotype replacements in hand, foot and mouth disease patients in Thailand, 2000–2017 | 2.3 | 40 | Citations (PDF) |
| 59 | Early and Late Virologic Failure After Virologic Suppression in HIV-Infected Asian Children and Adolescents | 1.9 | 11 | Citations (PDF) |
| 60 | The Use of Colistin for the Treatment of Multidrug-resistant Gram-negative Infections in Neonates and Infants | 1.3 | 30 | Citations (PDF) |
| 61 | Safety of 6-week Neonatal Triple-combination Antiretroviral Postexposure Prophylaxis in High-risk HIV-exposed Infants | 1.3 | 5 | Citations (PDF) |
| 62 | A Longitudinal Study of Behavioral Risk, Adherence, and Virologic Control in Adolescents Living With HIV in Asia | 1.9 | 13 | Citations (PDF) |
| 63 | Dual Analysis of Loss to Follow-up for Perinatally HIV-Infected Adolescents Receiving Combination Antiretroviral Therapy in Asia | 1.9 | 2 | Citations (PDF) |
| 64 | Nevirapine Concentrations During the First Month of Life and Maternal Efavirenz Washout in High-Risk HIV-Exposed Infants Receiving Triple Antiretroviral Prophylaxis | 1.3 | 2 | Citations (PDF) |
| 65 | Risk Factors for Human Papillomavirus Infection and Abnormal Cervical Cytology Among Perinatally Human Immunodeficiency Virus-Infected and Uninfected Asian Youth | 5.6 | 21 | Citations (PDF) |
| 66 | Persistence of hepatitis B immune memory until 9–10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months | 3.4 | 17 | Citations (PDF) |
| 67 | Adherence to antiretroviral therapy, stigma and behavioral risk factors in HIV-infected adolescents in Asia | 1.5 | 19 | Citations (PDF) |
| 68 | A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial | 8.9 | 32 | Citations (PDF) |
| 69 | Pharmacokinetics, Safety and Efficacy of Maraviroc in Treatment-experienced Pediatric Patients Infected With CCR5-Tropic HIV-1 | 1.3 | 11 | Citations (PDF) |
| 70 | Differences in activation and tissue homing markers of natural killer cell subsets during acute dengue infection | 4.8 | 15 | Citations (PDF) |
| 71 | Complete genome analysis demonstrates multiple introductions of enterovirus 71 and coxsackievirus A16 recombinant strains into Thailand during the past decade | 6.4 | 29 | Citations (PDF) |
| 72 | Characteristics, mortality and outcomes at transition for adolescents with perinatal HIV infection in AsiaAids, 2018, 32, 1689-1697 | 2.4 | 9 | Citations (PDF) |
| 73 | Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial | 8.9 | 38 | Citations (PDF) |
| 74 | B cell subset alteration and the expression of tissue homing molecules in dengue infected patients | 11.0 | 13 | Citations (PDF) |
| 75 | Clinical features and outcomes of Bacille Calmette-Guérin (BCG)-induced diseases following neonatal BCG Tokyo-172 strain immunization | 3.3 | 28 | Citations (PDF) |
| 76 | Identification of changes in dendritic cell subsets that correlate with disease severity in dengue infection | 2.5 | 19 | Citations (PDF) |
| 77 | Seroprevalence of Hepatitis B Among HIV-infected Children and Adolescents Receiving Antiretroviral Therapy in the TREAT Asia Pediatric HIV Observational Database | 1.3 | 4 | Citations (PDF) |
| 78 | The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis | 8.2 | 118 | Citations (PDF) |
| 79 | Persistence of Wild-Type Japanese Encephalitis Virus Strains Cross-Neutralization Five Years following JE-CV Immunization | 4.0 | 16 | Citations (PDF) |
| 80 | Attrition and Mortality of Children Receiving Antiretroviral Treatment through the Universal Coverage Health Program in Thailand | 2.0 | 13 | Citations (PDF) |
| 81 | Incidence of Postsuppression Virologic Rebound in Perinatally HIV-Infected Asian Adolescents on Stable Combination Antiretroviral Therapy | 1.9 | 9 | Citations (PDF) |
| 82 | Metabolic Disorders in HIV-Infected Adolescents Receiving Protease Inhibitors | 2.7 | 25 | Citations (PDF) |
| 83 | The Happy Teen programme: a holistic outpatient clinic‐based approach to prepare HIV‐infected youth for the transition from paediatric to adult medical care services in Thailand | 3.6 | 25 | Citations (PDF) |
| 84 | Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women | 7.3 | 183 | Citations (PDF) |
| 85 | B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts | 3.6 | 119 | Citations (PDF) |
| 86 | Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children | 3.3 | 13 | Citations (PDF) |
| 87 | Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India | 3.6 | 112 | Citations (PDF) |
| 88 | Early Height and Weight Changes in Children Using Cotrimoxazole Prophylaxis With Antiretroviral Therapy | 5.6 | 9 | Citations (PDF) |
| 89 | Vitamin D status in perinatally HIV-infected Thai children receiving antiretroviral therapy | 0.8 | 7 | Citations (PDF) |
| 90 | Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus | 7.5 | 522 | Citations (PDF) |
| 91 | Viral and atypical bacterial aetiologies of infection in hospitalised patients admitted with clinical suspicion of influenza in Thailand, Vietnam and Indonesia | 3.6 | 24 | Citations (PDF) |
| 92 | Using Lopinavir Concentrations in Hair Samples to Assess Treatment Outcomes on Second-Line Regimens Among Asian Children | 1.5 | 35 | Citations (PDF) |
| 93 | Hemophagocytic lymphohistiocytosis following dengue hemorrhagic fever in Hb H/Hb Constant Spring patient | 0.5 | 4 | Citations (PDF) |
| 94 | A Normal Reference of Bone Mineral Density (BMD) Measured by Dual Energy X-Ray Absorptiometry in Healthy Thai Children and Adolescents Aged 5–18 Years: A New Reference for Southeast Asian Populations | 2.5 | 48 | Citations (PDF) |
| 95 | Patient-Based Transcriptome-Wide Analysis Identify Interferon and Ubiquination Pathways as Potential Predictors of Influenza A Disease Severity | 2.5 | 25 | Citations (PDF) |
| 96 | Serotype distribution and antibiotic susceptibility of invasive<i>Streptococcus pneumoniae</i>isolates in patients aged 50 years or older in Thailand | 3.4 | 6 | Citations (PDF) |
| 97 | Characterizing HIV Manifestations and Treatment Outcomes of Perinatally Infected Adolescents in Asia | 1.3 | 34 | Citations (PDF) |
| 98 | Long-term outcomes of HIV-infected children in Thailand: the Thailand Pediatric HIV Observational Database | 2.3 | 23 | Citations (PDF) |
| 99 | Dengue Virus Infection Induces Expansion of a CD14+CD16+ Monocyte Population that Stimulates Plasmablast Differentiation | 10.6 | 241 | Citations (PDF) |
| 100 | Comparing Interferon-Gamma Release Assays to Tuberculin Skin Test in Thai Children with Tuberculosis Exposure | 2.5 | 17 | Citations (PDF) |
| 101 | Prevalence of Vitamin D Deficiency Among Perinatally HIV-infected Thai Adolescents Receiving Antiretroviral Therapy | 1.3 | 23 | Citations (PDF) |
| 102 | Challenges for the formulation of a universal vaccine against dengue | 2.6 | 19 | Citations (PDF) |
| 103 | Seroprevalence of 2009 H1N1 Virus Infection and Self-Reported Infection Control Practices Among Healthcare Professionals Following the First Outbreak in Bangkok, Thailand | 3.6 | 11 | Citations (PDF) |
| 104 | Development of a diagnosis disclosure model for perinatally HIV-infected children in Thailand | 1.5 | 19 | Citations (PDF) |
| 105 | Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavir | 3.2 | 3 | Citations (PDF) |
| 106 | Pharmacokinetics of Darunavir/Ritonavir in Asian HIV-1-Infected Children Aged ≥7 Years | 2.1 | 1 | Citations (PDF) |
| 107 | Pharmacokinetics and Safety of a New Paediatric Fixed-Dose Combination of Zidovudine/Lamivudine/Nevirapine in HIV-Infected Children | 2.1 | 34 | Citations (PDF) |
| 108 | Safety and Immunogenicity of a Single Administration of Live-attenuated Japanese Encephalitis Vaccine in Previously Primed 2- to 5-year-olds and Naive 12- to 24-month-olds | 1.3 | 74 | Citations (PDF) |
| 109 | Health-related Quality of Life of Thai children with HIV infection: a comparison of the Thai Quality of Life in Children (ThQLC) with the Pediatric Quality of Life Inventory™ version 4.0 (PedsQL™ 4.0) Generic Core Scales | 2.2 | 9 | Citations (PDF) |
| 110 | Cells in Dengue Virus Infection In Vivo | 1.1 | 61 | Citations (PDF) |
| 111 | A comparative study of the serological response to Japanese encephalitis vaccine in HIV-infected and uninfected Thai children | 3.3 | 17 | Citations (PDF) |
| 112 | Thai national guidelines for the use of antiretroviral therapy in pediatric HIV infection in 2010 | 0.8 | 17 | Citations (PDF) |
| 113 | A Re‐evaluation of the Mechanisms Leading to Dengue Hemorrhagic Fever | 4.6 | 48 | Citations (PDF) |
| 114 | Assessment of Bacille Calmette-Guerin Vaccine Reaction in HIV-Exposed Thai Infants | 5.6 | 5 | Citations (PDF) |
| 115 | Lack of resistant mutation development after receiving short-course zidovudine plus lamivudine to prevent mother-to-child transmissionAids, 2005, 19, 1231-1233 | 2.4 | 6 | Citations (PDF) |
| 116 | A Child With Avian Influenza A (H5N1) Infection | 1.3 | 86 | Citations (PDF) |
| 117 | Catch-up vaccination against Haemophilus influenzae type b in human immunodeficiency virus-infected Thai children older than 2 years old | 3.3 | 21 | Citations (PDF) |
| 118 | Low Risk of CD4 Decline After Immune Recovery in Human Immunodeficiency Virus-Infected Children With Viral Suppression | 1.5 | 1 | Citations (PDF) |
| 119 | Within-host evolutionary dynamics of seasonal and pandemic human influenza A viruses in young children | 1.6 | 15 | Citations (PDF) |
